From crystallographic analysis, Chaikuad and colleagues found that multiple ACVR1 mutations observed in FOP patients could destabilise the inactive state of the receptor, and mutations in the GS domain could impair inhibition by FKBP12 [50]. This evidence concerns the gene ACVR1 and fibrodysplasia ossificans progressiva.